Abstract: Small genetically-determined differences in transcription (eQTLs) are implicated in 25 complex disease but the mechanisms by which small changes in gene expression impact complex disease are unknown. Here we show that a persistent small increase in expression of the innate sensor NOD1 precipitates large cancer-promoting changes in cell state. A ~1.2-1.4 fold increase in NOD1 protein concentration by loss of miR-15b/16 regulation sensitizes cells to ligand-induced inflammation, with an additional slight increase leading to ligand-independent NOD1 activation 30 that is linked to poor prognosis in gastric cancer. Our data show that tight expression regulation of NOD1 prevents this sensor from exceeding a physiological switching checkpoint that promotes 2 persistent inflammation and oncogene expression and reveal the impact of a single small quantitative change in cell state on cancer.
persistent inflammation and oncogene expression and reveal the impact of a single small quantitative change in cell state on cancer.
Main Text:
The innate immune system employs a network of pattern recognition receptors to sense pathogens 5 or danger signals and mount an inflammatory response for host defense. However, chronic lowlevel stimulation of the immune system can lead to exaggerated responses (1) and cause uncontrolled tissue inflammation in genetically predisposed individuals, resulting in autoimmunity, autoinflammatory diseases, and cancers (2, 3). Recent studies indicate that in many cases, complex immune-related diseases are linked in genome-wide association studies (GWAS) 10 to causal variants located primarily in non-coding regions of genes, generating eQTLs (expression quantitative trait loci). The extent of expression variation between susceptible and resistant genotypes is often in the 1.5-3 fold range, suggesting that small changes in gene or gene product expression might play an important role in functional immune dysregulation (4) . While changes in protein concentration or activity due to defects in single genes have been implicated in 15 haploinsufficiencies and monogenic inflammatory or neurodegenerative syndromes (5) , it is unclear whether a single small alteration in protein concentration can impact the etiology of a multigenic, multifactorial disease like cancer. Recent studies across several cancer types have revealed a regulatory organization in which disease-promoting genomic modifications cluster upstream of functional master regulator proteins whose abnormal activity is necessary and 20 sufficient for propagating a tumor cell state (6). Importantly, their activity is controlled posttranscriptionally, and may be dysregulated, for example, by modulation of microRNA (miRNA) activity (7, 8) suggesting that small changes in protein expression of master regulators may induce cellular transformation to a cancerous state.
NOD1 is a ubiquitously expressed intracellular innate sensor of microbial infection that senses mesodiaminopimelic acid (iE-DAP, a component of bacterial peptidoglycan) (9, 10) and pathogeninduced alterations in cell state (11) to trigger nuclear factor-kB (NF-kB) and mitogen-activated protein kinase (MAPK) -dependent induction of pro-inflammatory genes. NOD1 activity is also 5 intimately linked to gastric cancer. Genetic variants in NOD1 are associated with gastric cancer risk and chronic activation of NOD1 by Helicobacter pylori is an initiating event in gastric cancer (12, 13) . During a study of NOD1 signaling, we discovered that very small changes in NOD1 expression spontaneously lead to large-scale cancer-associated gene activation in monocytes. A big-data approach further revealed that NOD1 is the most tightly regulated among many innate affecting endogenous NOD1 (Fig. 1D) . Low-level expression of 3X-FLAG NOD1 in the absence of DOX was also observed at the protein level by immunoblot at high exposures and by flow cytometry (Fig. 1E-F) . Correlation analysis revealed a very high concordance in genes differentially expressed upon low-level (i.e. -DOX) and DOX-induced expression of NOD1 (r 2 =0.9) but not in genes differentially expressed between low-level and DOX-induced expression 5 of NLRP4 (r 2 =0.01) (Fig. 1G) . These data suggest that a persistent small (1.5X) increase in expression of NOD1 leads to saturating gene activation in a ligand-independent, switch-like manner. A native gel analysis of NOD1 oligomerization showed that persistent 1.5X
overexpression of NOD1 induces oligomer formation similar to that seen with ligand ( Fig. S2A) .
Moreover, pro-inflammatory genes and negative feedback regulators previously reported to be 10 activated by NOD1 ligand including IL1B, JUN, NFKBIA/IkBa, and TNFAIP3/A20 (17) were upregulated in cells with sustained 1.5X increase in NOD1 expression (Table S3 and Fig. S2B) indicating that features of the ligand-induced NOD1 response are observed during ligandindependent activation. Importantly, our flow cytometry data ( Fig. 1F) showed that the small increase in NOD1 expression was distributed across the population suggesting that the gene 15 expression effects were not due to 'jack-potting' with very high expression of NOD1 in only a few of the THP-1 cells and emphasizing that it is the very modest 1.5X increase in NOD1 concentration that underlies the response phenomenon. Taken together these data indicate that NOD1 may be activated in a switch-like manner whereby a small increase in its expression mimics full activation.
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The finding that a sustained small change in NOD1 could lead to striking alterations in cellular state prompted a review of gene expression databases to determine how NOD1 compares to other innate immune sensors in terms of expression regulation. We applied a big data approach to systematically analyze publicly available gene expression data from >70,000 samples from the GEO database corresponding to five widely-used human microarray platforms (GPL96, 97, 571, 5175 and 6480; Table S4 ) and concluded that NOD1 exhibits the least variation in gene expression among known innate sensors regardless of the experimental context. To make datasets generated in different laboratories cross comparable, genome-wide expression data from each sample was 5 converted to robust z-scores ( Fig. 2A) . For each available probe corresponding to the innate sensors, the variability in distribution of z-score across all the samples was estimated from the standard deviation (SD). From this unbiased and data driven analysis, probes targeting the NOD1 gene consistently showed minimal deviation in gene expression across all microarray platforms ( Fig. 2B) , implying that NOD1 expression is under especially stringent control.
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MicroRNAs 15b and 16 tightly control NOD1 expression and activation
We next sought to uncover mechanisms of NOD1 expression control. One class of regulatory elements in the human genome that can exert tight but subtle control of protein expression usually in the less than 2 fold range (18) are small noncoding RNAs called miRNAs. The Affymetrix
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GeneChip Human 1.0 ST microarray used in our study contained probes for 210 pre-miRNAs.
Correlation analysis showed that the expression of the pre-miRNAs -mir-15b, mir-16-1 and mir-16-2 -was negatively correlated with NOD1 but not NOD2 or NLRP4 expression ( Fig. 3A and Table S5 ). Furthermore, the mature forms of these miRNAs (miR-15b and miR-16) were predicted to bind to the 3'-UTR of NOD1 in two independent miRNA-target prediction databases -
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TargetScan and miRanda ( Fig. S3A; by 60 min but this was followed by a restoration of miRNA expression at later times (Fig. 3C, left and middle panels); this later upswing may be indicative of a ligand-induced negative feedback response. In a reciprocal manner to the miRNAs, the expression of NOD1 very subtly increased 10 early after ligand stimulation. This was followed by a decline in NOD1 at later times both at the RNA (Fig. 3C, right panel) and the protein level (Fig. 3D) , which coincided with an increase in miR-15b/16 expression. Activation of NF-kB showed similar kinetics and peaked by 60 min after iE-DAP stimulation followed by a decrease by 4 h (Fig. S3B) .
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Because miR-15b/16 were predicted to bind the 3'-UTR of NOD1 (Fig. S3A) , we next examined if these miRNAs in turn control NOD1 expression. To test this, we used highly specific locked nucleic acids (LNA) to achieve short-term inhibition of miR-15b/16 activity in THP-1 cells and observed a subtle (30-40% or 1.3-1.4 fold) increase in NOD1 protein levels in cells transfected with miR-15b/16 LNA compared to cells transfected with control (scramble) LNA (Fig. 3E-F) .
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LNA targeting miR-191 had no effect. This phenomenon was also observed in CD14+ monocytes isolated from human blood (Fig. S3C-D) . Importantly, based on TargetScan and Miranda, binding sites for miR-15b/16 in the NOD1 3'-UTR are not conserved between humans and mice. Mouse
Nod1 was not predicted to be targeted by these miRNAs and consistent with this prediction inhibition of miR-15b/16 activity in mouse BMDM did not result in an increase in NOD1 protein levels ( Fig. S3E ) despite abundant expression of these miRNAs in mouse cells at levels similar to those in THP-1 cells (Fig. S3F) . These data indicate that miR-15b/16 control of NOD1 protein expression is specific to human cells. fold) increase in NOD1 expression (Fig. S4A) . This small increase in NOD1 enhanced ligandinduced p38 phosphorylation at all ligand concentrations and IkBα degradation at a suboptimal ligand concentration (Fig. S4B) , suggesting that miR-15b/16 exert their effect on NOD1 expression and signaling through their predicted binding site in the NOD1 3'-UTR.
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We next used a luciferase reporter assay system wherein luciferase activity was controlled by the intact NOD1 3'-UTR (WT) or a NOD1 3'-UTR in which the miR-15b/16 binding site had been mutated (miR-mut) (Fig. S5A ). Compared to a minimal 3'-UTR (ctrl) the WT NOD1 3'-UTR showed reduced luciferase activity when transfected into HEK-293 cells, and mutation of miR15b/16 binding site rescued this effect (Fig. S5B) . Co-transfection of the WT and miR-mutant 15 luciferase constructs with miR-15b or miR-16 mimics inhibited luciferase activity of the WT NOD1 3'-UTR but had no effect on the miR-15b/16 mutant NOD1 3'-UTR (Fig. S5C) . In contrast, co-transfection of luciferase constructs with LNA to miR-15b or miR-16 increased luciferase activity of the WT NOD1 3'-UTR (Fig. S5D) . Similar results were obtained with the miR-15b/16
TSB, which increased luciferase activity of the WT NOD1 3'-UTR but not the miR-15b/16 mutant 20 NOD1 3'-UTR (Fig. S5E) . These results show that miR-15b/16 directly control NOD1 expression through their specific binding sites in the NOD1 3'-UTR.
A prolonged small increase in NOD1 leads to activation of oncogenes
In contrast to miR-15b/16, which were negatively correlated with NOD1, our analyses in Fig. 1G revealed that genes whose expression had the greatest positive correlation with NOD1 expression (r 2 >0.7, fold change≥4) were mainly known proto-oncogenes including ALX1, c-KIT, CAV1, CNN2, CD68 and GPX8 ( that disrupted gene expression ( Fig. S7C-D) . Deletion of RIPK2 reduced the expression of cancerrelated genes to near-baseline levels ( expression as early as 1 h followed by a gradual tolerization of this inflammatory gene by 48-72 h (Fig. 5A) . A similar increase followed by a dampening effect was observed with other acute ligand-responsive genes, IL1B and TNFAIP3 (Fig. S8) ; the tolerization effect was also mirrored in cells with persistent 1.5X over-expression of NOD1, which showed lower abundance of these transcripts as compared to that observed at peak ligand stimulation (Fig. S2B) . In contrast, the 10 expression of c-MYC followed reverse kinetics with delayed upregulation between 52-60 h after ligand stimulation which coincided with dampening of the classical ligand-dependent genes (Fig.   5A ). These data indicate that sustained ligand exposure leads to a delayed shift to oncogene induction. Second, we induced prolonged disruption of miR-15b/16 mediated regulation of NOD1
by treatment of cells with miR-15b/16 TSB that inhibits miRNA binding specifically to the NOD1 15 3'UTR. This led to a small increase in endogenous NOD1 protein by 24 h which was sustained until day 8 of TSB treatment and was accompanied by a significant induction of proto-oncogenes by day 3 ( Fig. 5B-C) . Lastly, we genetically targeted miR-15b and miR-16 in THP-1 cells by CRISPR-Cas9 gene editing in order to achieve a long-term reduction in expression of these miRNAs. miR-15b and miR-16 are present contiguously within an intronic region of the same 20 gene (SMC4) and we found that gRNAs targeting miR-15b also significantly reduced miR-16 expression ( Fig. 5D and S9) . Importantly, prolonged reduction in miR-15b/16 expression led to a 1.5 to 2 fold increase in endogenous NOD1 (Fig. 5D ) and spontaneous induction of cancer-related genes (Fig. 5E ). Collectively these data show that a prolonged small increase in NOD1 expression either by transgenic expression from a lentiviral construct or an increase in endogenous NOD1 by disruption of miR-15b/16 function, mimics long-term ligand stimulation and induces expression of proto-oncogenes.
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A subtle increase in NOD1 predicts poor prognosis in gastric cancer patients
Because a sustained small increase in NOD1 expression was responsible for induction of cancerrelated genes, we next asked if dysregulation of miRNA-mediated control of NOD1 expression is penetrant in human cancer. We first measured correlation between NOD1 and miR-15b/16 levels in RNA-Seq data from normal vs tumor tissue across 33 different cancer types in The Cancer
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Genome Atlas (TCGA). This analysis showed that the negative correlation between NOD1 and miR-15b/16 in normal tissue was most significant in STAD (stomach adenocarcinoma) ( Fig. S10 and Table S6 ). This negative correlation was reduced in tumor tissue, suggesting impaired miRNA control of NOD1 in gastric cancer ( Fig. S10 and S11A ). These findings are consistent with previous reports showing that NOD1 expression is increased in patients with gastritis and its drop in tumor tissue was not observed for the closely related NLR, NOD2, suggesting that regulation by miR-15b/16 is seemingly specific to NOD1 (Fig. 6A) . Expression of NOD1, but not NOD2, was subtly elevated in gastric tumors by ~1.5X when compared to control tissue, an increase consistent with impaired miRNA-mediated regulation of NOD1 expression (Fig. 6B-C) .
We next analyzed expression of miRNAs and NOD1 at different stages of the disease, which
showed that progression of STAD is associated with increased NOD1 and decreased miRNA expression ( Fig. 6D and S11B-C) . Taken together, these results imply that reduced expression of miR-15b/16 and a corresponding small increase in NOD1 expression is linked to lethal gastric 5 cancer progression.
Dysregulation of miRNA is a well-known feature of cancer. Because a given gene can in principle be targeted by multiple miRNAs, we hypothesized that impaired control of NOD1 expression in gastric cancer may be a phenomenon regulated by miRNAs beyond miR-15b and miR-16. We 10 therefore expanded our analysis to include all miRNAs that were negatively correlated with NOD1 expression in normal gastric tissue (r-value between -0.5 and -1) and were also predicted to bind the 3'-UTR of NOD1, thereby making them likely candidates to regulate NOD1 expression. We analyzed correlation of this subset of miRNAs with all NLRs in the TCGA STAD dataset. In healthy gastric tissue, expression of these miRNAs showed the highest negative correlation with
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NOD1 compared to all other NLRs (Fig. S12A-B) . This inverse correlation was reduced in tumor tissue indicating that miRNA control of NOD1 is globally impaired in gastric tumors. We next asked if a small increase in NOD1 expression is linked to disease prognosis. To investigate this,
we performed meta-analysis of gene expression and survival data from 876 gastric cancer patients (31), segregating patients into low and high NOD1 expressers with a fold difference of ~1.64 20 between these groups. The results showed that elevated NOD1 expression is a significant predictor of early disease mortality (Fig. 6E) . NOD1 and miR-15b/16 may thus serve as biomarkers or predictors of disease prognosis in gastric cancer. Taken together these data imply that miRNAs likely constitute a critical control mechanism that keeps NOD1 expression in check in normal tissue. A small increase in NOD1 is associated with greater disease mortality, underscoring the importance of stringent control mechanisms needed to restrain NOD1 expression.
Discussion
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The human genome contains a large number of regulatory elements that modulate gene activity at Recent studies across several cancer types reveal a tumor regulatory architecture wherein functional master regulator proteins whose abnormal activity is necessary and sufficient for implementing a tumor cell state, integrate the effects of multiple and heterogeneous upstream 5 genomic alterations (6). In this regard, by virtue of its ability to induce increased expression of cancer-associated genes, NOD1 may itself act as a master regulator whose altered activity propagates a tumor cell state. Recent studies implicate the requirement of at least two signals to transform a normal cell into a tumor cell (37, 38). We think it is unlikely that short-term activation of NOD1 alone is sufficient to spur tumor development in otherwise normal stomach tissue 10 because ligand-induced, scaled activation of NOD1 appears to trigger negative feedback mechanisms resulting in repression of NOD1 expression (Fig. 3C) . Thus, under normal conditions, NOD1 activation is counterbalanced by repression of its expression. To shift this balance towards chronic NOD1 expression it is likely that a disruption of miR-15b/16 and/or other miRNAs that restrict NOD1 expression is required. Importantly, a small increase in NOD1 due to disruption of 15 miR-15b/16 control of its expression brings NOD1 levels closer to the ligand-independent threshold and sensitizes cells to inflammatory responses in response to otherwise inert concentrations of ligand (Fig. 3G-H and S4A-B) , a state that might permit usually innocuous commensal products to activate inflammatory responses to a greater degree than when miRNA control is intact. Disruption of one or more mechanisms that sustain miRNA expression thus likely 20 constitutes an initial trigger that unleashes the inflammatory potential of NOD1, thereby creating an microenvironment that drives oncogenesis (3).
Taken together, our data emphasize that very small prolonged changes in protein concentration can have dramatic effects on cell state that can be penetrant in a disease as complex and multifactorial as cancer. Rather than the 'Knockout = large effect' studies that have captivated the field for decades, these data emphasize the need to consider in a more quantitative and subtle way how polygenic diseases may evolve in susceptible hosts over years through a sustained small shift interests. Data and materials availability: Reagents described in this study are available to the 10 scientific community upon request to N.S. Microarray data generated in this study is available at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE99550 and can be accessed for review using the secure token 'qzajcmwurdcrhkx'. Cancer datasets analyzed in this study are publicly available through The Cancer Genome Atlas and the Kaplan Meier plotter. All other data is available in the main text or the supplementary materials.
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